Launch of Andriol Testocaps announced

Published: 2004-09-06 06:57:00

Updated: 2004-09-06 06:57:00

Organon Korea said it will launch in Korea an oral Andriol Testocaps (testosterone undecanoate) medication for the treatment of climacteric disorders in men, including testosterone deficiency such as hypogonadism, andropause and related conditions.

Andriol Testocaps is an orally active testost...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK